LFCR — Lifecore Biomedical Share News
0.000.00%
Last trade - 00:00- $242.60m
- $380.42m
- $128.87m
U.S. RESEARCH ROUNDUP- Ally Financial, GE Vernova, Navient
Brief: Lifecore Biomedical Sees 2024 Rev In The Range Of $125 mln to $130 mln
Brief: Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession And Board Changes
Lifecore Biomedical Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Lifecore Biomedical Announces Receipt Of Nasdaq Notice Of Delisting And Intention To Appeal
Brief: Lifecore Biomedical Receives Notice From Nasdaq Regarding Delayed Quarterly Report
Brief: Lifecore Biomedical Expands Relationship With Existing Long-Term Customer Through A Series Of Commercial Arrangements
Lifecore Biomedical Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Lifecore Biomedical Provides Business Update
Brief: Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation
Brief: Lifecore Bio Says Co's Audit Committee Concluded FY 22 And FY 21 Statements Should No Longer Be Relied Upon
Brief: Lifecore Biomedical Receives Notice From Nasdaq Regarding Delayed Quarterly Report
Brief: Lifecore Biomedical Inc Receives Notice From Nasdaq Regarding Delayed Annual Report
Brief: Lifecore Biomedical Provides Update For Development Portfolio And Timing Of Delayed Filings
Lifecore Biomedical Inc expected to post a loss of 23 cents a share - Earnings Preview
Lifecore Biomedical Inc reports results for the quarter ended in May - Earnings Summary
Lifecore Biomedical Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Lifecore Biomedical, Inc. Receives Notice From Nasdaq Regarding Delayed Annual Report
Lifecore Biomedical Inc expected to post a loss of 37 cents a share - Earnings Preview